Member Info for cashfornuthin

Absolutely :)

With long-term safety and efficacy profile, milciclib could potentially be the first-in-class targeted therapy for patients with thymic carcinoma and thymoma without any satisfactory treatment option today �

Nice rns..money raised recently at around this price and at year low'ish.

Unbelievable.....lol..cheap cheap.

Great news..nice steady rise before the Big One..atb

Cannot believe this price !!!

Friday...small amount..company seems sorted..shot to nothing.

This week...friday flourish to end ? CE getting close now...atb

Added as well

Surely this time.

So 2 or 3 sells since friday morning...amazing. Think a big % day is not far away. Should really be flying past year high. atb.

Sure there is a song there.

Interesting no sells all day that I can see. Healthy right enough . atb

Sounds like a subtle hint !

Just have to hold everyone and we will be off :)

Should encourage some buying.

Liking the sound of that. Good start to the week.

Mighty buys in here.

Same old....soon change hopefully.

Agree..might finish blue you never know.